Clinical Trial Update: Low Vision Intervention Trial II (LOVIT II) [Phase 2]

View source ↗

Summary

LOVIT II Phase 2 trial evaluating a low vision intervention for central vision loss from macular diseases has completed and posted results in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Central Vision Loss From Macular Diseases

Snippet

Sponsor: VA Office of Research and Development | Conditions: Central Vision Loss From Macular Diseases | Phase 2 | Status: COMPLETED | Results posted: 2016-08-25